Polysaccharide peptides from Coriolus versicolor competitively inhibit tolbutamide 4-hydroxylation in specific human CYP2C9 isoform and pooled human liver microsomes

Phytomedicine

Volumn 18, Issue 13, 2011, Pages 1170-1175

  Yeung, John H K ^a   Or, Penelope M Y ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

4 Hydroxytolbutamide; Coriolus versicolor; Human CYP2C9; Polysaccharide peptide (PSP); Tolbutamide metabolism

Indexed keywords

4 HYDROXYTOLBUTAMIDE; CYTOCHROME P450 2C11; CYTOCHROME P450 2C9; HYDROXYTOLBUTAMIDE; POLYPEPTIDE; POLYSACCHARIDE; POLYSACCHARIDE PEPTIDE; SULFAPHENAZOLE; TOLBUTAMIDE; UNCLASSIFIED DRUG;

ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG INHIBITION; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; HERB DRUG INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER MICROSOME; PRIORITY JOURNAL; TRAMETES VERSICOLOR;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CORIOLACEAE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HUMANS; HYDROXYLATION; MICROSOMES, LIVER; PLANT EXTRACTS; PLANTS, MEDICINAL; PROTEOGLYCANS; RATS; TOLBUTAMIDE;

RATTUS; TRAMETES VERSICOLOR;

EID: 80053913470     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2011.06.002     Document Type: Article

References (29)

1. S.L. Chan, and J.H.K. Yeung Effects of polysaccharide peptide (PSP) from Coriolus versicolor on the pharmacokinetics of cyclophosphamide in the rat and cytotoxicity in HepG2 cells Food Chem. Toxicol. 44 2006 689 694
2. S.L. Chan, and J.H.K. Yeung Modulation of antipyrine clearance by polysaccharide peptide isolated from Coriolus versicolor in the rat Food Chem. Toxicol. 44 2006 1607 1612 (Pubitemid 43994267)
3. T.K. Chang, G.F. Weber, C.L. Crespi, and D.J. Waxman Differential activation of cyclophosphamide and ifosphamide by cytochromes P450 2B and 3A in human liver microsomes Cancer Res. 53 1993 5629 5637 (Pubitemid 23360263)
4. V.A. Eagling, J.F. Tjia, and D.J. Back Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes Br. J. Clin. Pharmacol. 45 1998 107 114 (Pubitemid 28045676)
5. J. Easterbrook, D. Fackett, and A.P. Li A comparison of aroclor 1254-induced and uninduced rat liver microsomes to human liver microsomes in phenytoin O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-mephenytoin 4′-hydroxylation, chloroxazone 6-hydroxylation and testosterone 6β-hydroxylation Chem. Biol. Interact. 134 2001 243 249 (Pubitemid 32406147)
6. B.C. Foster, J.T. Arnason, and C.J. Briggs Natural health products and drug disposition Annu. Rev. Pharmacol. Toxicol. 45 2005 203 226 (Pubitemid 40261803)
7. P. Go, and C.H. Chung Adjuvant PSK immunotherapy in patients with carcinoma of the nasopharynx J. Int. Med. Res. 17 1989 141 149 (Pubitemid 19100697)
8. K. Hayakawa, N. Mitsuhashi, Y. Saito, M. Takahashi, S. Katano, K. Shiojima, M. Furuta, and H. Niibe Effect of krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer Anticancer Res. 13 1993 1815 1820
9. Z. Hu, X. Yang, P.C.L. Ho, S.Y. Chan, P.W.S. Heng, E. Chan, W. Duan, H.L. Koh, and S. Zhou Herb-drug interactions: a literature review Drugs 65 9 2005 1239 1282 (Pubitemid 41038418)
10. P.M. Kidd The use of mushroom glucans and proteoglycans in cancer treatment Altern. Med. Rev. 5 2000 4 27 (Pubitemid 30132069)
11. J. Kirchheiner, and J. Brockmoller Clinical consequences of cytochrome P450 2C9 polymorphisms Clin. Pharmacol. Ther. 77 2005 1 16 (Pubitemid 40089477)
12. Y. Kodama, T. Kano, R. Tamada, R. Kumashiro, T. Okamura, and K. Inokuchi Combined effect of prophylactic lymphadenectomy and long term combination chemotherapy for curatively resected carcinoma of the stomach Jap. J. Surgery 12 1982 244 248 (Pubitemid 13227105)
13. J.X. Liu, J.Y. Zhou, and T.F. Liu Phase III clinical trial for the Yun Zhi polysacchride (PSP) capsules Q.Y. Yang, Advanced Research in PSP 1999 1999 The Hong Kong Association for Health Care Limited Hong Kong 295 303
14. T. Mitomi, S. Tsuchiya, N. Iijima, K. Aso, K. Suzuki, K. Nishiyama, T. Amano, T. Takahashi, N. Murayama, and H. Oka Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa) Dis. Colon Rectum 35 1992 123 130
15. J.A. Monro Treatment of Cancer with mushroom products Arch. Environ. Health 58 2003 533 537 (Pubitemid 38828874)
16. K. Ogoshi, H. Satou, K. Isono, T. Mitomi, M. Endoh, and M. Sugita Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study Cancer Invest. 13 1995 363 369
17. A.E. Rettie, and J.P. Jones Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics Annu. Rev. Pharmacol. Toxicol. 45 2005 477 494 (Pubitemid 40267790)
18. M.E. Veronese, M.E. Mcmanus, P. Laupattarakasem, J.O. Minors, and D.J. Birkett Tolbutamide hydroxylation by human, rabbit and rat liver microsomes by purified forms of cytochrome P450 Drug Metab. Dispos. 18 1990 356 361 (Pubitemid 20174252)
19. S.Y. Wang, M.L. Hu, and X.T. Yang Growth inhibition and apoptosis in human leukemia cells induced by cytokines released from PSP-activated blood mononuclear cells. Q.Y. Yang, Advanced Research in PSP 1999. 1999 The Hong Kong Association for Health Care Limited Hong Kong 128 130
20. X. Wang, C.M. Cheung, W.Y.W. Lee, P.M.Y. Or, and J.H.K. Yeung Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro Phytomedicine 17 2010 868 875
21. Q.Y. Yang, Y.J. Hu, X.Y. Li, J.C. Yang, J.X. Liu, T.F. Liu, G.M. Xu, and M.L. Liao A new biological response modifier substance - PSP Q.Y. Yang, C.Y. Kwok, 1993 PSP International Symposium, Anthology of Theses and Abstracts 1993 Fudan University Press Shanghai 55 72
22. J.H. Yeung, L.C. Chiu, and V.E. Ooi Effect of polysaccharide peptide (PSP) on glutathione and protection against paracetamol-induced hepatotoxicity in the rat Methods Find Exp. Clin. Pharmacol. 16 1994 723 729
23. J.H.K. Yeung, L.C.M. Chiu, and V.E. Ooi Effect of polysaccharide peptide (PSP) on in vivo sulphation and glucuronidation of paracetamol in the rat Eur. J. Drug Metab. Pharmacokinet. 20 1995 287 292 (Pubitemid 26129072)
24. J.H.K. Yeung, S.L. Chan, and P.M.Y. Or Polysaccharide peptides from COV-1 strain of Coriolus versicolor inhibit tolbutamide 4-hydroxylation in the rat in vitro and in vivo Food Chem. Toxicol. 44 2006 1414 1423
25. L.Y. Zhang, Y. Zhong, and J. Zhou The observation of PSP decrease 60 cases chemotherapeutical stomach cancer's side effect Q.Y. Yang, Advanced Research in PSP 1999 1999 The Hong Kong Association for Health Care Limited Hong Kong 328
26. S. Zhou, Y. Gao, W. Jiang, M. Huang, A. Xu, and J.W. Paxton Interactions of herbs with cytochrome P450 Drug Metab. Rev. 35 2003 35 98 (Pubitemid 36249785)
27. S. Zhou, L.Y. Lim, and B. Chowbay Herbal modulation of P-glycoprotein Drug Metab. Rev. 36 2004 57 104 (Pubitemid 38387835)
28. Y.L. Zhou, and Q.Y. Yang Active principles from Coriolus SP Q.Y. Yang, Advanced Research in PSP 1999 The Hong Kong Association for Health Care Limited Hong Kong 111 124
29. J. Zhang, Q. Tian, Y.S. Chan, S.C. Li, S. Zhou, W. Duan, and Y.Z. Zhu Metabolism and transport of oxazaphosphorines and the clinical implications Drug Metab. Rev. 37 2005 611 703 (Pubitemid 43071142)